Advanced Search

 

Study ID Status Title Patient Level Data
29060/041 Completed A Study to Assess the Efficacy and Tolerability of Paroxetine by Double-Blind Comparison of Morning and Evening Dosages
29060/042 Completed A Study to Assess the Efficacy and Tolerability of Paroxetine by Double-Blind Comparison of Morning and Evening Doses in the Elderly.
29060/043 Completed An Interim Report of a Study to Assess the Effectiveness and Tolerance of Paroxetine in Depressed Patients by Double-Blind Comparison with Amitriptyline (A follow-up final report was not prepared and is not expected for this study).
29060/044 Completed A Double-blind Comparative Two-centre Study to Assess the Efficacy and Tolerability of Paroxetine (20mg vs 30mg) in Elderly Depressed Patients
29060/046 Completed A Study to Assess the Efficacy and Tolerance of Paroxetine in Elderly Depressed Patients by Double-Blind Comparison with Amitriptyline
29060/048 Completed A study to assess the interaction of paroxetine with digoxin in normal healthy volunteers
29060/049 Completed A Multi-Centre General Practice Study to Compare the Effectiveness and Tolerability of Paroxetine in Elderly Depressed Patients by Double Blind Comparison with Amitriptyline
29060/051 Completed A study to compare the bioequivalence of two formulations of paroxetine, a 30 mg tablet and 3 x10 mg capsules
29060/052 Completed A study to compare the bioequivalence of two formulations of paroxetine: a 30 mg film-coated tablet and a 30 mg caplet
29060/053 Completed A Double-Blind, Placebo Controlled, Comparative Investigation of the Effects on Psychomotor Performance of Paroxetine and Amitriptyline with or without alcohol in Adult Subjects.
29060/056 Completed A double-blind, between patient, multicentre study in general practice comparing the efficacy and tolerability of paroxetine with those of dothiepin in the treatment of elderly depressed patients
29060/057 Completed A Double-blind comparative multicentre study of paroxetine plus supportive psychotherapy and psychotherapy alone in the prevention of recurrent suicidal behavior and episodes of intermittent brief depression Study Listed on ClinicalStudyDataRequest.com
29060/058 Completed A double-blind, placebo controlled, randomised, single dose, cross-over study comparing the effects on objective and subjective sleep, and awakening and early morning behaviour, of paroxetine 20 mg, 30 mg and 40 mg morning dose, 30 mg evening dose, and fluoxetine 40 mg morning dose in healthy vo ...
29060/061 Completed A Double-blind Comparative Study Comparing Paroxetine b.d. (twice daily) with Fluoxetine b.d. (twice daily) in Geriatric Patients with Major Depression
29060/062 Completed An Interaction Study of Paroxetine on Lithium Plasma Levels in Depressed Patients Stabilised on Lithium Therapy
29060/063 Completed A double blind randomised trial comparing the effects on sleep of paroxetine 30mg daily and amitriptyline 150mg daily in patients with major depression.
29060/064 Completed A Double-blind Comparative Multicentre Study Comparing Paroxetine b.d. (twice daily) with Fluoxetine b.d. (twice daily) in Depressed Patients
29060/065 Completed A Double-blind Comparative Study Comparing Paroxetine 20mg-40mg/day with Maprotiline 50mg-150mg/day in Major Depression: Clinical and Biochemical Aspects
29060/067 Completed A combined Report on the Clinical Aspects of Three Pharmacokinetic Studies of Paroxetine in the Treatment of Major Depressive Disorder (DSM III)
29060/069 Completed A Multicentre, Parallel Group Study to Compare the Efficacy and Tolerability of Paroxetine with Clomipramine in Elderly Patients.
29060/07/001 Completed A Double-Blind Comparison of Paroxetine, Amitriptyline, and Placebo in Inpatients with Major Depressive Disorder with Melancholia Study Listed on ClinicalStudyDataRequest.com
29060/070 Completed A multicentre, double-blind, parallel group, randomised dose study comparing the efficacy of paroxetine 20mg increasing to 30mg daily if there is insufficient response and clomipramine 60mg increasing to 75mg daily, in outpatients (age >60 years) with moderate depression according to…
29060/073 Completed A Multicentre, Double-blind Randomised Dose Titration Study Comparing the Efficacy and Safety Profiles of an Increasing Dose Regimen of Oral Paroxetine and Oral Amitriptyline in Adult Patients with Major Depression
29060/075 Completed A Sub-Chronic Comparison of the Effects of Paroxetine Versus those of Amitriptyline and Placebo on Fundamental Perceptual-Motor Skills and Actual Driving Performance
29060/076 Completed The Effects of Paroxetine Versus Those of Maprotiline and Placebo on Fundamental Cognitive Functions, Perceptual-Motor Skills and Eye Movements in Depressed Patients

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.